Join to View Full Profile
201 N. BroadwayBaltimore, MD 21287
Dr. Saloura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2011 - 2014
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2008 - 2011
University of AthensClass of 2004
Certifications & Licensure
MD State Medical License 2020 - 2025
IL State Medical License 2011 - 2020
PA State Medical License 2008 - 2011
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS Start of enrollment: 2025 Apr 29
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- SMYD3 drives cell cycle and epithelial-mesenchymal transition pathways through dual gene transcriptional repression and activation in HPV-negative head and neck cancer.Madhavi Murali, Abbas Saeed, Sohyoung Kim, Kyunghee Burkitt, Hui Cheng
Scientific Reports. 2025-01-06 - 1 citationsSmyd3-mediated immuno-modulation in HPV-negative head and neck squamous cell carcinoma mouse models.Daniel E Tsai, Alexei Lovanov, Abdalla Abdelmaksoud, Jawad Akhtar, Mohd Saleem Dar
Iscience. 2024-09-20 - 3 citationsIntegrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas.Hidenori Machino, Ai Dozen, Mariko Konaka, Masaaki Komatsu, Kohei Nakamura
Experimental & Molecular Medicine. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
